First-Time Generic Approvals: Niaspan, Allegra-D 12 Hour, Monistat 3
May 3, 2005 — The U.S. Food and Drug Administration has approved first-time generic formulations of niacin extended-release 500-, 750-, and 1,000-mg tablets for the treatment of hypercholesterolemia; fexofenadine HCl plus pseudoephedrine HCl 60-mg/120-mg extended-release tablets for the treatment of seasonal allergic rhinitis and chronic idiopathic urticaria in adults and children aged six years or […]